Table 2. The incidence of adverse events in the safety population (n=37).

Adverse events	Any grade, n (%)	Grade 3–4, n (%)
Non-hematological
Hypertension	11 (29.7)	1 (2.7)
Proteinuria	10 (27.0)	–
Hand-foot syndrome	12 (32.4)	2 (5.4)
Fatigue	7 (18.9)	1 (2.7)
Anorexia	11 (29.7)	–
Abdominal pain	10 (27.0)	–
Diarrhea	12 (32.4)	1 (2.7)
Dizziness	6 (16.2)	–
Elevated transaminase	14 (37.8)	–
Elevated bilirubin	6 (16.2)	–
Mucositis	4 (10.8)	–
Acute intestinal obstruction	–	1 (2.7)
Upper gastrointestinal bleeding	–	1 (2.7)
Hematological
Anemia	15 (40.5)	1 (2.7)
Leukopenia	12 (32.4)	1 (2.7)
Thrombocytopenia	7 (18.9)	–